97184 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
METHOD FOR THE REDUCTION OF HOST CELL PROTEINS IN AFFINITY CHROMATOGRAPHY
#2PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#3DRUG CONDITIONING REGIMEN FOR SICKLE CELL DISEASE
#4Anti-Peripheral Lymph Node Addressin Antibodies and Uses Thereof
#5P-SELECTIN INHIBITION FOR TREATMENT OF CANCER
#6GASDERMIN-D INHIBITORS AND USES THEREOF FOR TREATING PULMONARY VASO-OCCLUSION
#7TREATMENT REGIMENS
#8USE OF an anti-P-selectin antibody
#9Bispecific Molecules and Related Compositions and Methods
#10METHOD OF MODULATING CELL PROLIFERATION
#11ANTI-E-SELECTIN ANTIBODIES, COMPOSITIONS AND METHODS OF USE
#12Recombinant Fusion Proteins Targeting P-selectin, and Methods of Use Thereof for Treating Diseases and Disorders
#13ENGINEERED CELLS AND METHODS OF USE
#14PSGL-1 MODULATORS AND USES THEREOF
#15P-SELECTIN INHIBITOR, COMPOSITIONS THEREOF AND METHODS OF USE THEREOF
#16CRIZANLIZUMAB CONTAINING ANTIBODY FORMULATIONS
#17USE OF THE ANTI-P-SELECTIN ANTIBODY CRIZANLIZUMAB FOR TREATING SICKLE CELL NEPHROPATHY AND CHRONIC KIDNEY DISEASE ASSOCIATED WITH SICKLE CELL DISEASE
#18Use of an Anti-P-selectin Antibody
#19Method for the reduction of host cell proteins in affinity chromatography
#20Method for the reduction of host cell proteins in affinity chromatography
#21METHODS AND COMPOSITIONS FOR REDUCING NUMBERS OR ELIMINATING HIV-INFECTED CELLS
#22CD62L specific lentiviral vector particle for targeted transduction of T cell subsets
#23Methods of Inhibiting Metastasis in Cancer
#24Recombinant Fusion Proteins Targeting P-selectin, and Methods of Use Thereof for Treating Diseases and Disorders
#25Anti-peripheral lymph node addressin antibodies and uses thereof
#26Anti-E-selectin antibodies, compositions and methods of use
#27MODIFIED MITOCHONDRIA AND USE THEREOF
#28Anti-variant Fc-region antibodies and method of use
#29PSGL-1 MODULATORS AND USES THEREOF
#30Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using
#31EXPRESSION VECTOR ORGANIZATION, NOVEL PRODUCTION CELL GENERATION METHODS AND THEIR USE FOR THE RECOMBINANT PRODUCTION OF POLYPEPTIDES
#32EXPRESSION VECTOR ELEMENT COMBINATIONS, NOVEL PRODUCTION CELL GENERATION METHODS AND THEIR USE FOR THE RECOMBINANT PRODUCTION OF POLYPEPTIDES
#33USE OF an anti-P-selectin antibody
#34Method of modulating cell proliferation
#35Anti-peripheral lymph node addressin antibodies and uses thereof
#36Insulin immunoglobulin fusion proteins
#37PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF THROMBOSIS IN PATIENTS SUFFERING FROM A MYELOPROLIFERATIVE NEOPLASM
#38TREATMENT REGIMENS
#39COMPOSITIONS AND METHODS FOR NON-MYELOABLATIVE CONDITIONING
#40Methods and kits for predicting the risk of having or developping hepatocellular carcinoma in patients suffering from cirrhosis
#41Engineered cells and methods of use
#42PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#43Hemoglobin modifier compounds and uses thereof
#44METHODS OF INHIBITING METASTASIS IN CANCER
#45PROTEIN EXPRESSION FROM MULTIPLE NUCLEIC ACIDS
#46Insulin immunoglobulin fusion proteins
#47METHODS FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS (HIV) RELEASE FROM INFECTED CELLS
#48Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using
#49Anti-variant Fc-region antibodies and method of use
#50Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptides
#51Method for the reduction of host cell proteins in affinity chromatography
#52Method for the reduction of host cell proteins in affinity chromatography
#53Anti-PMEL17 antibodies and immunoconjugates
#54PSGL-1 modulators and uses thereof
#55Anti-P Selectin Antibodies and Methods of Their Use and Identification
#56EXPRESSION VECTOR ELEMENT COMBINATIONS, NOVEL PRODUCTION CELL GENERATION METHODS AND THEIR USE FOR THE RECOMBINANT PRODUCTION OF POLYPEPTIDES
#57Anti-PMEL17 antibodies and immunoconjugates
#58Methods for Treating Corneal and Conjunctival Inflammation and Inflammatory Disorders
#59Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptides
#60Protein expression from multiple nucleic acids
#61Stem Cell Fusion Model of Carcinogenesis
#62Phage antibodies to radiation-inducible neoantigens
#63Methods of treating sickle cell disease with anti-P-selectin antibodies
#64Anti-PMEL17 antibodies and immunoconjugates
#65Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy
#66Activatable Constructs
#67INHIBITION OF LEUKOCYTE ADHESION
#68FORMULATION COMPRISING AN ANTIBODY AGAINST P-SELECTIN
#69Therapeutic compositions and methods for targeted delivery of active agents
#70Stem Cell Fusion Model of Carcinogenesis
#71HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENOMICE
#72Phage antibodies to radiation-inducible neoantigens
#73Methods Of Inhibiting Inflammation-Associated Tissue Damage By Inhibiting Neutrophil Activity
#74Stable aqueous pharmaceutical formulations of daclizumab antibodies
#75Anti-P-selectin antibodies
#76Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases
#77ANTI-P-SELECTIN ANTIBODIES AND METHODS OF THEIR USE AND IDENTIFICATION
#78Recombinant expression vector elements (REVES) for enhancing expression of recombinant proteins in host cells
#79Cytokine induction of selectin ligands on cells
#80STABLE LIQUID PHARMACEUTICAL FORMULATION OF IGG ANTIBODIES
#81Compositions comprising E-selectin antagonists and uses therefor
#82Treatment of immunocompromised conditions
#83Protein expression from multiple nucleic acids
#84CHO-K1 CELL LINE
#85Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies
#86Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy
#87NOVEL ANTIBODY FORMULATION
#88Human antibodies derived from immunized xenomice
#89Nucleic acid molecules encoding anti-P-selectin antibodies
#90Methods for the treatment and prevention of infection using anti-selectin agents
#91Human antibodies derived from immunized xenomice
#92NOVEL P-SELECTIN LIGAND PROTEIN
#93Cytokine induction of selectin ligands on cells
#94P-selectin ligand protein
#95Nucleic acids encoding P-selectin ligand fusion proteins
#96Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
#97Inhibition of leukocyte adhesion
#98Phage antibodies to radiation-inducible neoantigens
#99Protein (poly)peptides libraries
#100Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy
#101Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
#102Methods of screening for anti-inflammatory drugs and use thereof
#103Therapeutic liposome composition and method of preparation
#104Human antibodies derived from immunized xenomice
#105Protein (poly)peptides libraries
#106Human antibodies derived from immunized xenomice
#107Methods of treating traumatic spinal cord injury
#108Anti-P-selectin antibodies
#109Activation and expansion of cells
#110Therapeutic liposome composition and method of preparation
#111Activation and expansion of cells
#112Therapeutic liposome composition and method of preparation
#113Generation of xenogeneic antibodies
#114Human antibodies derived from immunized xenomice
#115Methods for treating ischemic disorders using carbon monoxide